Employers and employees could fall into opposing camps, with workers demanding t...
Have you ever received test results in your email and found yourself panic-Googl...
Confo Therapeutics’s technology stabilises the selected GPCRs in their disease-r...
Healthcare R&D teams are increasingly using AI for drug development. Learn more ...
The use of AI in clinical trials is improving pharmaceutical R&D, speeding up ti...
Developing a new drug is a monumental achievement — the reward of years of resea...
The sNDA was submitted based on data obtained from the Phase III NAPOLI 3 trial.
PEMRYDI RTU is the first and only ready-to-use presentation of pemetrexed for in...
The company hopes to work with stakeholders to improve access to biosimilars acr...
Eloxx reanalysed data from a Phase II trial that previously missed its efficacy ...
Cullgen received a $35m upfront payment and is eligible for several milestone-ba...
Lilly will work on the development, manufacture and commercialisation activities...
“It’s a setback in patient safety and surveillance,” one expert said, "and will ...
Endometriosis is in dire need of treatments, and a new study implicating a type ...
A top UnitedHealth executive said there's been “a meaningfully higher number” of...
This was supposed to be the new Biogen. Instead, the company's board saddled CEO...
